Analyses in human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as candidate bladder cancer biomarkers

Biochemical and Biophysical Research Communications

Volumn 438, Issue 1, 2013, Pages 48-53

  Köhler, Christina U ^a   Bryk, Oleksandr ^a   Meier, Swetlana ^a   Lang, Kerstin ^a   Rozynek, Peter ^a   Brüning, Thomas ^a   Käfferlein, Heiko U ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Bladder cancer; DNA methylation; MiRNA expression; Primary urothelial cells; Urothelial cell lines

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; MICRORNA 10A; MICRORNA 152; MICRORNA 200B; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DNA RESTRICTION; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC REGULATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UROTHELIUM;

5-AZA-2′-DEOXYCYTIDINE; AZA; BLADDER CANCER; DNA METHYLATION; HUEPC; HUMAN UROTHELIAL EPITHELIAL CELLS; MIRNA EXPRESSION; PRIMARY UROTHELIAL CELLS; UROTHELIAL CELL LINES;

CELL LINE, TUMOR; CELLS, CULTURED; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84881549300     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.07.021     Document Type: Article

References (31)

1. Parkin D.M. The global burden of urinary bladder cancer. Scand. J. Urol. Nephrol. Suppl. 2008, 218:12-20.
2. Halling K.C., King W., Sokolova I.A., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J. Urol. 2000, 164:1768-1775.
3. Têtu B. Diagnosis of urothelial carcinoma from urine. Mod. Pathol. 2009, 22(Suppl. 2):53-59.
4. Roos P.H., Jakubowski N. Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids. Bioanalysis 2010, 2:295-309.
5. Hoffman A.M., Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics 2011, 3:19-34.
6. Tang G. SiRNA and miRNA: an insight into RISCs. Trends Biochem. Sci. 2005, 30:106-114.
7. Fendler A., Stephan C., Yousef G.M., et al. microRNAs as regulators of signal transduction in urological tumors. Clin. Chem. 2011, 57:954-968.
8. Snowdon J., Boag S., Feilotter H., et al. A pilot study of urinary microRNA as a biomarker for urothelial cancer. Can. Urol. Assoc. J. 2012, 15:1-5.
9. Puerta-Gil P., García-Baquero R., Jia A.Y., et al. MiR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Am. J. Pathol. 2012, 180:1808-1815.
10. Wang G., Chan E.S., Kwan B.C., et al. Expression of microRNAs in the urine of patients with bladder cancer. Clin. Genitourin. Cancer 2012, 10:106-113.
11. Zabolotneva A.A., Zhavoronkov A., Garazha A.V., et al. Characteristic patterns of microRNA expression in human bladder cancer. Front. Genet. 2012, 3:310.
12. Sánchez-Carbayo M. Hypermethylation in bladder cancer: biological pathways and translational applications. Tumour Biol. 2012, 33:347-361.
13. Chung W., Bondaruk J., Jelinek J., et al. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiol. Biomarkers Prev. 2011, 20:1483-1491.
14. Cabello M.J., Grau L., Franco N., et al. Multiplexed methylation profiles of tumor suppressor genes in bladder cancer. J. Mol. Diagn. 2011, 13:29-40.
15. Costa V.L., Henrique R., Danielsen S.A., et al. Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples. Clin. Cancer Res. 2010, 16:5842-5851.
16. Lin H.H., Ke H.L., Wu W.J., et al. Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection. Urol. Oncol. 2012, 30:177-181.
17. Lopez-Serra P., Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 2012, 31:1609-1622.
18. Liep J., Rabien A., Jung K. Feedback networks between microRNAs and epigenetic modifications in urological tumors. Epigenetics 2012, 7:315-325.
19. Davalos V., Esteller M. MicroRNAs and cancer epigenetics: a macrorevolution. Curr. Opin. Oncol. 2010, 22:35-45.
20. Sandoval J., Esteller M. Cancer epigenomics: beyond genomics. Curr. Opin. Genet. Dev. 2012, 22:50-55.
21. Ehrich M., Nelson M.R., Stanssens P., et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl. Acad. Sci. USA 2005, 102:15785-15790.
22. Cumming G., Fidler F., Vaux L. Error bars in experimental biology. J. Cell. 2010, 177(1):7-11.
23. Lim H.W., Iwatani M., Hattori N., et al. Resistance to 5-aza-2'-deoxycytidine in genic regions compared to non-genic repetitive sequences. J. Reprod. Dev. 2010, 56:86-93.
24. Dudziec E., Miah S., Choudhry H.M.Z., et al. Hypermethylation of GpC islands and shores around specific microRNAs and Mirtrons is associated with the phenotype and presence of bladder cancer. Clin. Cancer Res. 2011, 17:1287-1296.
25. Adam L., Zhong M., Choi W., et al. MiR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin. Cancer Res. 2009, 15:5060-5072.
26. Gregory P.A., Bert A.G., Paterson E.L., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10:593-601.
27. McConkey D.J., Choi W., Marquis L., et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev. 2009, 28:3-4.
28. Wiklund E.D., Bramsen J.B., Hulf T., et al. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int. J. Cancer 2011, 128:1327-1334.
29. Wszolek M.F., Rieger-Christ K.M., Kenney P.A., et al. A microRNA expression profile defining the invasive bladder tumor phenotype. Urol. Oncol. 2011, 29:794-801.
30. Zhu J., Jiang Z., Gao F., et al. A systematic analysis on DNA methylation and the expression of both mRNA and microRNA in bladder cancer. PLoS One 2011, 6:e28223.
31. Veerla S., Lindgren D., Kvist A., et al. MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int. J. Cancer 2009, 124:2236-2242.